The Discounted Cash Flow (DCF) valuation of Paratek Pharmaceuticals Inc (PRTK) is (43.10) USD. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on DCF is -2032.8%.
Based on the latest price of 2.23 USD and our DCF valuation, Paratek Pharmaceuticals Inc (PRTK) is a sell. selling PRTK stocks now will result in a potential gain of 2032.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.5% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (111.25) - (28.35) | (43.10) |
| Upside | -5088.9% - -1371.2% | -2032.8% |